According to previous researches, O6-methylguanine-DNA methyltransferase (MGMT), which causes the replication of DNA and the growth of malignant gliomas via removal of the alkylating lesion at the O6 position of guanine, may partially contribute to glioma resistance to TMZ therapy [41, 42]. Here, MGMT is linked to central nervous system cancer.